effects of stopping semaglutide Semaglutide: How to Keep the Weight Off The infographic compares 10 commonly

No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide

The FDA specifically approved this medication for patients with obesity and weight-related health complications, which accurately describes my medical situation

Gastric Emptying Modulation GLP2 transiently delays gastric emptying, similar to selective GLP-1 receptor agonists: Slowed rate of nutrient absorption from the gastrointestinal tract Reduced postprandial glucose excursions Effect is most pronounced after initial doses and diminishes with continued treatment Contributes to improved glycemic control through multiple complementary mechanisms Central Nervous System Effects Appetite Regulation Both GIP and GLP-1 receptors are expressed in brain regions controlling appetite and food intake: Reduced food intake and appetite through central nervous system receptor activation Promotion of satiety signals leading to decreased caloric consumption Potential modulation of reward-related feeding behaviors Weight loss effects that appear mediated through both homeostatic and hedonic feeding pathways Clinical trials have demonstrated substantial weight reduction, with participants experiencing decreased appetite as a commonly reported effect of GLP2 treatment

BioTRUST GLP-1 Elevate is getting strong feedback from people who used it in hopes of getting better control over their appetite and eating habits

Seven to eight hours of quality sleep supports the hormonal environment necessary for continued progress